Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (145)	1/27/1998 2:16:00 PM
From: scaram(o)uche	Respond to of 579

More on the numbers for Dr. Harpold..... The 5/9/96 IPO went out the door at $11/share. As of 12/31/95, Comer had 260,850 exercisable securities underlying unexercised options with an in-the-money value of $500. That's "five hundred". Similarly, Dr. Harpold had 155,394/$182,000. Since, as of 3/19/96, there were options out under the '81 plan for 24,675 shares of common exercisable at an average exercise price of $5.78, I guess that it's feasible that Dr. Harpold let some options expire?? Sort of hard to tell since they were private for so long.... no old proxy statements to fly with.